Friday Q&A: Biosense Webster’s Brooks and Hong talk about cardiac ablation

The leaders of Johnson & Johnson’s Biosense Webster unit see growth opportunities with new cardiac ablation technologies, despite a crowded field that includes Abbott, Boston Scientific and Medtronic.